Papers from every journal, all in one place. Erstelle eigene Feeds.
Perioperative dapagliflozin reduces postoperative AKI; extends SGLT2i use to cardiac surgery prevention.

nephrologist, Baylor College of Medicine
Hereon, investigators should aim to better understand the mechanism(s) by which SGLT2 inhibitors reduce the risk of AKI among patients undergoing elective cardiac surgery as well as those with type 2 diabetes, heart failure, and chronic kidney disease treated with SGLT2 inhibitors longer-term. Moreover, they should briskly and rigorously conduct randomized, placebo-controlled clinical trials of SGLT2 inhibitors in established AKI, aiming to arrest or attenuate its evolution and/or hasten its recovery.
Clinicians should integrate extracranial bleeding risk into OAC decisions for AF; this meta-analysis extends trial data by quantifying baseline factors' contribution to most attributable risk.
Persistent severe AS pathway delays warrant targeted workflow reforms now; extends evidence base for digital and organizational interventions.

First RCT of anti-inflammatory therapy in post-COVID cardiac involvement; leaves open whether losartan plus prednisolone improves symptoms or imaging.

Peer Reviewer, Springer Nature
The manuscript is well written, the introduction and aim are easy to follow, and the results are somewhat easy to follow. Notwithstanding, this reviewer is somewhat uneasy about the presentation of the changes in anatomical and functional measurements.
BP lowering shows no outcome benefit in HFmrEF/HFpEF; leaves open whether it mediates therapy effects or warrants targeted trials.

Hypertrabeculation in DCM was not linked to higher embolic risk; leaves open its prognostic value across genotypes in prospective studies.

Cardiologist, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
The presence of hypertrabeculation did not modify clinical risk in any of the genetic subgroups analyzed, confirming that it does not confer a worse prognosis.
Low BP control persisted after 2017 guideline and during COVID; leaves open how to overcome therapeutic inertia in incident hypertension.

May guide cardioprotective drug selection during breast cancer chemotherapy; extends comparative RCT evidence on LVEF preservation.

May support interpretable ECG analysis for PVC localization; leaves open prospective validation before clinical use.

Diagnostic delays may occur in young adults with high BP, especially men; leaves open whether targeted screening improves timely diagnosis.
